Left atrial structure and function and the risk of death or heart failure in atrial fibrillation

The present study aimed to assess the association between left atrial (LA) structure and function and the risk for cardiovascular (CV) death or heart failure (HF) hospitalization in a population with atrial fibrillation (AF).

[1]  B. Gersh,et al.  Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[2]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[3]  D. Levy,et al.  Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. , 2016, Circulation.

[4]  L. Chen,et al.  Decade-long trends in atrial fibrillation incidence and survival: a community study. , 2015, The American journal of medicine.

[5]  M. Allessie,et al.  Atrial Electrophysiologic Remodeling: Another Vicious Circle? , 1998, Journal of cardiovascular electrophysiology.

[6]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[7]  S. Solomon,et al.  The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[8]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[10]  M. Link,et al.  Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48) , 2017, Circulation. Arrhythmia and electrophysiology.

[11]  E. Antman,et al.  Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial. , 2016, The American journal of medicine.

[12]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  J. Butler,et al.  Global left atrial failure in heart failure , 2016, European journal of heart failure.

[14]  C. Ayers,et al.  Left atrial structure and function and clinical outcomes in the general population. , 2013, European heart journal.

[15]  M. Kawasaki,et al.  Left atrial global and regional function in patients with paroxysmal atrial fibrillation has already been impaired before enlargement of left atrium: velocity vector imaging echocardiography study. , 2012, European heart journal cardiovascular Imaging.

[16]  James B Seward,et al.  Left atrial size: physiologic determinants and clinical applications. , 2006, Journal of the American College of Cardiology.

[17]  H. Uno,et al.  Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. , 2008, European heart journal.

[18]  M. Chung,et al.  Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  L. Jordaens,et al.  Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[20]  M. Piepoli,et al.  Left Atrial Function Predicts Cardiovascular Events in Patients With Chronic Heart Failure With Reduced Ejection Fraction , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[21]  H. Hillege,et al.  MORTALITY IN PATIENTS WITH ATRIAL-FIBRILLATION IS RELATED TO THE UNDERLYING HEART-DISEASE AND NOT TO THE ARRHYTHMIA , 1994 .

[22]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[23]  S. Solomon,et al.  Left Atrium in Heart Failure With Preserved Ejection Fraction: Structure, Function, and Significance , 2014, Circulation. Heart failure.

[24]  M. Cameli,et al.  Left atrial deformation analysis by speckle tracking echocardiography for prediction of cardiovascular outcomes. , 2012, The American journal of cardiology.

[25]  R. Palma dos Reis,et al.  Left atrial function index predicts long-term survival in stable outpatients with systolic heart failure , 2017, European heart journal cardiovascular Imaging.

[26]  Deepak K Gupta,et al.  Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. , 2014, European heart journal.

[27]  B. Hoit,et al.  Left atrial size and function: role in prognosis. , 2014, Journal of the American College of Cardiology.

[28]  D. Levy,et al.  Response to Letter Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction". , 2016, Circulation.

[29]  E. Antman,et al.  Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF‐TIMI 48 , 2014, European journal of heart failure.

[30]  E. Antman,et al.  Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). , 2010, American heart journal.

[31]  W. Abhayaratna,et al.  Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance. , 2017, JACC. Cardiovascular imaging.

[32]  S. Solomon,et al.  Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy , 2010, Circulation.

[33]  Mary A Whooley,et al.  Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study. , 2012, Journal of the American College of Cardiology.